EXECUTIVE ENGAGEMENTS
POOL
3476
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
626
Interactions with Platform & by Email
PARTICIPANTS
104
Unique # Participated
VALIDATIONS
32
Responses Validated*
COMPANIES
44
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
140
PAGES
214
EDITION
6
PRICE
USD 5450
CODE
MCP15020
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Stem Cell Assay estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2027, growing at a CAGR of 20.1% over the analysis period 2020-2027. Viability/Cytotoxicity, one of the segments analyzed in the report, is projected to record a 22.4% CAGR and reach US$1.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Isolation & Purification segment is readjusted to a revised 18.7% CAGR for the next 7-year period.
The Stem Cell Assay market in the U.S. is estimated at US$332.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$685.2 Million by the year 2027 trailing a CAGR of 19.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18% and 17.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.6% CAGR.
In the global Cell Identification segment, USA, Canada, Japan, China and Europe will drive the 20.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$102.9 Million in the year 2020 will reach a projected size of US$370.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$485.7 Million by the year 2027.
SELECT PLAYERS
Bio-Rad Laboratories, Inc.; Bio-Techne Corporation; Cell Biolabs, Inc.; Cellular Dynamics International; GE Healthcare; HemoGenix, Inc.; Merck & Co., Inc.; Miltenyi Biotec GmbH; PerkinElmer, Inc.; Promega Corporation; Stemcell Technologies Canada, Inc.; Thermo Fisher Scientific, Inc.
SEGMENTS
» Type (Viability/Cytotoxicity, Isolation & Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis) » Cell Type (Adult Stem Cells, hESCs) » Product (Instruments, Kits, Services) » Application (Regenerative Medicine, Clinical Research, Drug Discovery & Development)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Stem Cell Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Stem Cell Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027 |
| World Current & Future Analysis for Cell Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Cell Identification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Differentiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Differentiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Isolation & Purification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Isolation & Purification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Proliferation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Proliferation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Viability/Cytotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Viability/Cytotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Apoptosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Apoptosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for hESCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for hESCs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Biopharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Biopharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2020 & 2027 |
| USA Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2020 & 2027 |
| USA Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2020 & 2027 |
| USA Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2020 & 2027 |
| USA Current & Future Analysis for Stem Cell Assay by End-Use - Biopharmaceutical & Biotechnology Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Stem Cell Assay by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Biotechnology Companies and Research Institutes for the Years 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Stem Cell Assay by End-Use - Biopharmaceutical & Biotechnology Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Stem Cell Assay by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Biotechnology Companies and Research Institutes for the Years 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Stem Cell Assay by End-Use - Biopharmaceutical & Biotechnology Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Stem Cell Assay by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Biotechnology Companies and Research Institutes for the Years 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2020 & 2027 |
| China Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2020 & 2027 |
| China Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2020 & 2027 |
| China Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2020 & 2027 |
| China Current & Future Analysis for Stem Cell Assay by End-Use - Biopharmaceutical & Biotechnology Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Stem Cell Assay by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Biotechnology Companies and Research Institutes for the Years 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Stem Cell Assay by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Stem Cell Assay by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027 |
| Europe Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Stem Cell Assay by End-Use - Biopharmaceutical & Biotechnology Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Stem Cell Assay by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Biotechnology Companies and Research Institutes for the Years 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2020 & 2027 |
| France Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2020 & 2027 |
| France Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2020 & 2027 |
| France Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2020 & 2027 |
| France Current & Future Analysis for Stem Cell Assay by End-Use - Biopharmaceutical & Biotechnology Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Stem Cell Assay by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Biotechnology Companies and Research Institutes for the Years 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Stem Cell Assay by End-Use - Biopharmaceutical & Biotechnology Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Stem Cell Assay by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Biotechnology Companies and Research Institutes for the Years 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Stem Cell Assay by End-Use - Biopharmaceutical & Biotechnology Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Stem Cell Assay by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Biotechnology Companies and Research Institutes for the Years 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2020 & 2027 |
| UK Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2020 & 2027 |
| UK Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2020 & 2027 |
| UK Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2020 & 2027 |
| UK Current & Future Analysis for Stem Cell Assay by End-Use - Biopharmaceutical & Biotechnology Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Stem Cell Assay by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Biotechnology Companies and Research Institutes for the Years 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Stem Cell Assay by End-Use - Biopharmaceutical & Biotechnology Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Stem Cell Assay by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Biotechnology Companies and Research Institutes for the Years 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Stem Cell Assay by End-Use - Biopharmaceutical & Biotechnology Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Stem Cell Assay by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Biotechnology Companies and Research Institutes for the Years 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Stem Cell Assay by Type - Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Stem Cell Assay by Type - Percentage Breakdown of Value Sales for Cell Identification, Differentiation, Isolation & Purification, Proliferation, Viability/Cytotoxicity, Function and Apoptosis for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Stem Cell Assay by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Stem Cell Assay by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Stem Cell Assay by Product - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Stem Cell Assay by Product - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Stem Cell Assay by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Stem Cell Assay by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Stem Cell Assay by End-Use - Biopharmaceutical & Biotechnology Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Stem Cell Assay by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Biotechnology Companies and Research Institutes for the Years 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 44 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com